Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Smoking is considered an important “risk factor” for arterial hypertension and diabetes management, according to, respectively, the current guidelines of the European Society of Hypertension and the European Society of Cardiology on the management of arterial hypertension (1) and the guidelines on diabetes of the European Society of Cardiology and the European Association for the Study of Diabetes (2). The aim of the current article is to further evaluate the effect of smoking on mortality and cause-specific cardiovascular events in hypertension and in diabetes and to assess whether there is a significant interaction between the effects of smoking and diabetes. To assess the effect of smoking on mortality and cause-specific cardiovascular events, and the interaction between smoking and diabetes, we analyzed a database of 3,468 hypertensive patients without major cardiovascular disease at baseline and with prospective follow-up for morbidity and mortality (3). The database consists of individual data of hypertensive patients from four prospective studies performed in Europe (4–7). Age of the subjects averaged 61 ± 13 years (mean ± SD), 45% were men, and 61% were under antihypertensive treatment at baseline. Office blood pressure averaged 159.0 ± 19.9/91.0 ± 11.7 mmHg and 24-h ambulatory blood pressure 138.1 ± 16.4/82.3 ± 11.0 mmHg. Current smoking and diabetes were coded as yes or no at the baseline examination; 13.7% of the patients smoked and 8.4% had diabetes. We used Cox proportional hazards regression analysis to assess the prognostic significance of smoking, with stratification for study and adjustment for age, sex, diabetes, total cholesterol, 24-h systolic blood pressure, antihypertensive treatment, and BMI. The average 24-h blood pressure was used because its predictive power has been shown to be superior to that of office blood pressure (3). Median follow-up time was 6.57 years (range 0.08–13.1) and total follow-up time amounted to …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Staessen, J. A. (1999) · JAMA · doi:10.1001/jama.282.6.539 · Cited by 1,592
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., de Leeuw, P. W., Duprez, D. A., Fagard, R. H., Gheeraert, P. J., Missault, L. H., Braun, J. J., Six, R. O., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022273 · Cited by 1,085
Self-citationThe UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084 · cited 4×
“The studies include the First National Health and Nutrition Examination Survey (13), a large case-control study (14), the World Health Organization Multinational Study of Vascular Disease in Diabetes (15,16), the U.K. Prospective Diabetes Study (UKPDS) (17–19), the Nurses’ Health Study Cohort (20,21), and the Swedish…”
BackgroundInfluentialPrediction of First Events of Coronary Heart Disease and Stroke With Consideration of Adiposity
Wilson, P. W. F., Bozeman, S. R., Burton, T. M., Hoaglin, D. C., Ben-Joseph, R., & Pashos, C. L. (2008) · Circulation · doi:10.1161/circulationaha.108.772962 · Cited by 174
Smoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus
Al-Delaimy, W. K., Manson, J. E., Solomon, C. G., Kawachi, I., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.273 · Cited by 173 · cited 4×
“The studies include the First National Health and Nutrition Examination Survey (13), a large case-control study (14), the World Health Organization Multinational Study of Vascular Disease in Diabetes (15,16), the U.K. Prospective Diabetes Study (UKPDS) (17–19), the Nurses’ Health Study Cohort (20,21), and the Swedish…”
BackgroundInfluentialRisk Prediction of Cardiovascular Disease in Type 2 Diabetes
Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Nilsson, P. M., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2008) · Diabetes Care · doi:10.2337/dc08-0662 · Cited by 173
Cited by
Pharmacist Interventions to Improve Cardiovascular Disease Risk Factors in Diabetes
Santschi, V., Chiolero, A., Paradis, G., Colosimo, A. L., & Burnand, B. (2012) · Diabetes Care · doi:10.2337/dc12-0369 · Cited by 145
“Because smoking amplifies the risk of CVD among patients with diabetes (37) and may have deleterious effect on diabetes control (38), studies are needed to assess the impact of pharmacist care to reduce the risk of smoking among patients with diabetes.”
BackgroundHigh-Throughput Screening to Identify Chemical Cardiotoxic Potential
Krishna, S., Berridge, B., & Kleinstreuer, N. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00382 · Cited by 52
Reid, R. D., Malcolm, J., Wooding, E., Geertsma, A., Aitken, D., Arbeau, D., Blanchard, C., Gagnier, J.-A., Gupta, A., Mullen, K.-A., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1809 · Cited by 30
“There is a direct, positive relationship between number of cigarettes smoked per day and risk for coronary heart disease, stroke, and proteinuria (21,22).”
Background
Metadata
- Authors
- Fagard, R. H.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S429-S431
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2168068525
- Cited by
- 77
- References
- 7
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes. https://app.cochat.ai/papers/10.2337/dc09-s354
- The paper
- Fagard, R. H. (2009). Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes. Diabetes Care. https://doi.org/10.2337/dc09-s354
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.